VP for Information Technology and Chief Information Officer at University of San Francisco and Saama Clinical Board of Advisors Member, Opinder Bawa, published an article on PharmExec.com examining the role of AI in life science industry transformation through a historical lens.
“Today we see how AI substantially increases or effectively disrupts clinical trial supply chain efficiency – i.e. identifying, recruiting, and retaining patients; collecting data; core analysis; early interventions with potential subjects, etc. – and is proving essential to the successful conduct of future clinical trials and their outcomes. Those outcomes of AI-powered solutions also offer unprecedented opportunity to inform and alter daily healthcare in ways that will reap additional benefits for patients in the not-too-distant future.”
Read the full article here.
Access Out-of-the-Box Features in 4 Weeks—Guaranteed.
Saama can put you on the fast track to clinical trial process innovation.